<code id='D1EBCC8C6E'></code><style id='D1EBCC8C6E'></style>
    • <acronym id='D1EBCC8C6E'></acronym>
      <center id='D1EBCC8C6E'><center id='D1EBCC8C6E'><tfoot id='D1EBCC8C6E'></tfoot></center><abbr id='D1EBCC8C6E'><dir id='D1EBCC8C6E'><tfoot id='D1EBCC8C6E'></tfoot><noframes id='D1EBCC8C6E'>

    • <optgroup id='D1EBCC8C6E'><strike id='D1EBCC8C6E'><sup id='D1EBCC8C6E'></sup></strike><code id='D1EBCC8C6E'></code></optgroup>
        1. <b id='D1EBCC8C6E'><label id='D1EBCC8C6E'><select id='D1EBCC8C6E'><dt id='D1EBCC8C6E'><span id='D1EBCC8C6E'></span></dt></select></label></b><u id='D1EBCC8C6E'></u>
          <i id='D1EBCC8C6E'><strike id='D1EBCC8C6E'><tt id='D1EBCC8C6E'><pre id='D1EBCC8C6E'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:knowledge    Page View:793
          Senate health committee Chair Bernie Sanders
          Sen. Berne Sanders (I-Vt.) Kevin Dietsch/Getty Images

          WASHINGTON — Sen. Bernie Sanders (I-Vt.) has a new corporate target: the food industry.

          Sanders held a hearing today on diabetes that implicated both the food and drug industries in what the American Diabetes Association estimates is a $413 billion annual cost to the health care system. That’s up 27% over the past six years, he said, and he warned that new weight loss drugs could send health care spending to the stratosphere.

          advertisement

          But the food industry received more attention, especially from Sanders, than the drugmakers and drug middlemen.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Sports medicine is finally prioritizing gender equality
          Sports medicine is finally prioritizing gender equality

          MollyFergusonforSTATWhencyclistAlisonTetrickjoinedthesport’sprofessionalranks,shereceivedtheperkstha

          read more
          Biotech stock slump in 2023: awaiting the turnaround
          Biotech stock slump in 2023: awaiting the turnaround

          AdobeThiswassupposedtobetheyearofthebiotechcomeback,whenpromisingnewmedicinesandhigh-dollarbuyoutswo

          read more
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more

          CommonSpirit Health keeps growing, even as it loses money

          CommonSpirit,oneofthecountry’sbiggesthealthsystems,keepsgrowingitshospitalcountanddebt,evenasitloses